Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Item

http://www.wikidata.org/entity/Q37144895

Q37144895

about

Abacavir/lamivudine combination in the treatment of HIV: a review.Lack of association between stavudine exposure and lipoatrophy, dysglycaemia, hyperlactataemia and hypertriglyceridaemia: a prospective cross sectional study Abacavir/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV.Abacavir increases platelet reactivity via competitive inhibition of soluble guanylyl cyclase Combination nucleoside/nucleotide reverse transcriptase inhibitors for treatment of HIV infection.Pharmacokinetics of abacavir and its anabolite carbovir triphosphate without and with darunavir/ritonavir or raltegravir in HIV-infected subjects.Plasma pharmacokinetics of once-daily abacavir- and lamivudine-containing regimens and week 96 efficacy in HIV-infected Thai children Quantification of cell-associated atazanavir, darunavir, lopinavir, ritonavir, and efavirenz concentrations in human mononuclear cell extracts.Mass spectrometry in the quantitative analysis of therapeutic intracellular nucleotide analogs.Clinical pharmacology profile of raltegravir, an HIV-1 integrase strand transfer inhibitor.Abacavir and lamivudine for the treatment of human immunodeficiency virus.Clinical pharmacokinetics and pharmacodynamics of dolutegravir used as a single tablet regimen for the treatment of HIV-1 infection.Liquid chromatography-mass spectrometry methods for the intracellular determination of drugs and their metabolites: a focus on antiviral drugs.Out of focus: tailoring the cascade of care to the needs of women living with HIV.Dolutegravir and elvitegravir plasma concentrations following cessation of drug intake.Pharmacokinetic study of once-daily versus twice-daily abacavir and lamivudine in HIV type-1-infected children aged 3-<36 months.Stress Degradation Behavior of Abacavir Sulfate and Development of a Suitable Stability-Indicating UHPLC Method for the Determination of Abacavir, its Related Substances, and Degradation Products.Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots following Directly Observed Therapy: the DOT-DBS Study.Simultaneous quantification of intracellular lamivudine and abacavir triphosphate metabolites by LC-MS/MS.

P2860

Q33715435-854F730B-8334-4E35-9FDE-203357F43450 Q34039225-E38DC564-CE20-4FC8-A639-D282BD7775C3 Q35233168-81859795-0337-49A2-A59F-E2CADE42C326 Q35737682-99B5B34F-D225-402A-AD9C-6FE1A4D81904 Q36097686-6896743D-1C4D-4301-AC42-ACBEAFC5D01A Q37077340-03B1B120-EC48-4FEE-A5B4-F1AD8BF86B42 Q37098376-E42B5F21-B416-4941-883D-F37ED6BF38B6 Q37713065-46627A41-6C32-4617-B7AD-01633EA23D24 Q37771921-36A7D104-BE7C-4791-A0A9-2CD47786CE0F Q37826300-D4D10D7A-CD5B-40E7-BB59-DF50A8846B49 Q37905058-6F742894-8570-4161-8B72-A2AA5574EFB8 Q38541809-90CD390D-6672-4743-A132-98E8B9501692 Q39434360-EAA6C389-111A-4E30-B8DA-BEE44EC15ABD Q40062892-2A511170-58CE-4FBF-B4E2-469EDE0F95BB Q40199953-2783162B-2F53-4CC4-B917-802FB91DC749 Q41881433-0E46AAEB-A711-4A4E-87D5-92999F0F589C Q42425202-A46201CF-B385-4994-9A32-8ED922021C6E Q46323872-DB23A082-8179-41B2-9D47-18A12FCD5C0A Q52666512-D3C81EC9-059A-4471-B0F8-7C9C6D2C9566

P2860

Steady-state pharmacokinetics of abacavir in plasma and intracellular carbovir triphosphate following administration of abacavir at 600 milligrams once daily and 300 milligrams twice daily in human immunodeficiency virus-infected subjects.

Item

http://www.wikidata.org/entity/Q37144895

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 02 February 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs